GGrantIndex
← Leaderboards

Kevin Keewoun Kim

University Of Michigan At Ann Arbor

$6,577,422
Attributed
$9,016,863
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,016,863 · 5

By mechanism

R01$8,336,056 · 3
K08$625,455 · 1
F32$55,352 · 1

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Fibroblasts

Research focus

FibroblastsPulmonary FibrosisFibrosisPathway InteractionsEpithelial CellsSignal TransductionCellsRegulationAnimal ModelInjuryLungLeadAlveolarCessation Of LifeBleomycinPhenotypeMesenchymalLung InjuryResponseProgramsIn VivoComplicationProteinsTissues

Grant awards (24)

Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary Fibrosis$605,325
R01 · FY2025 · HL · contact PI
Oxidized Phospholipids Derived from Apoptotic Pneumocytes Drives Macrophage Activation and Initiates Lung Fibrosis$604,667
R01 · FY2024 · HL · contact PI
Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary Fibrosis$593,218
R01 · FY2024 · HL · contact PI
Oxidized Phospholipids Derived from Apoptotic Pneumocytes Drives Macrophage Activation and Initiates Lung Fibrosis$617,007
R01 · FY2023 · HL · contact PI
Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary Fibrosis$606,273
R01 · FY2023 · HL · contact PI
Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary Fibrosis$618,378
R01 · FY2022 · HL · contact PI
Oxidized Phospholipids Derived from Apoptotic Pneumocytes Drives Macrophage Activation and Initiates Lung Fibrosis$617,007
R01 · FY2022 · HL · contact PI
Oxidized Phospholipids Derived from Apoptotic Pneumocytes Drives Macrophage Activation and Initiates Lung Fibrosis$617,007
R01 · FY2021 · HL · contact PI
Type I collagen signaling in lung injury and fibrosis$374,565
R01 · FY2020 · HL · contact PI
Type I collagen signaling in lung injury and fibrosis$383,166
R01 · FY2019 · HL · contact PI
Type I collagen signaling in lung injury and fibrosis$390,892
R01 · FY2018 · HL · contact PI
Type I collagen signaling in lung injury and fibrosis$397,068
R01 · FY2017 · HL · contact PI
Function of epithelial-mesenchymal transition during pulmonary fibrosis$388,750
R01 · FY2016 · HL · contact PI
Function of epithelial-mesenchymal transition during pulmonary fibrosis$382,918
R01 · FY2015 · HL · contact PI
Function of epithelial-mesenchymal transition during pulmonary fibrosis$380,975
R01 · FY2014 · HL · contact PI
Function of epithelial-mesenchymal transition during pulmonary fibrosis$370,090
R01 · FY2013 · HL · contact PI
Function of epithelial-mesenchymal transition during pulmonary fibrosis$388,750
R01 · FY2012 · HL · contact PI
Alpha3Beta Integrin Function in Epithelial-Mesenchymal Transition and Fibrosis$125,820
K08 · FY2011 · HL · contact PI
Alpha3Beta Integrin Function in Epithelial-Mesenchymal Transition and Fibrosis$121,204
K08 · FY2010 · HL · contact PI
Alpha3Beta Integrin Function in Epithelial-Mesenchymal Transition and Fibrosis$4,616
K08 · FY2010 · HL · contact PI
Alpha3Beta Integrin Function in Epithelial-Mesenchymal Transition and Fibrosis$125,415
K08 · FY2009 · HL · contact PI
Alpha3Beta Integrin Function in Epithelial-Mesenchymal Transition and Fibrosis$124,200
K08 · FY2008 · HL · contact PI
Alpha3Beta Integrin Function in Epithelial-Mesenchymal Transition and Fibrosis$124,200
K08 · FY2007 · HL · contact PI
Beta 1 Integrins and Cellular Responses to TGFbeta$55,352
F32 · FY2005 · GM